BCPC Quote, Financials, Valuation and Earnings

5E Advanced Materials has a net margin of 14.1% compared to Balchem's net margin of --. Balchem's return on equity of 11.16% beat 5E Advanced Materials's return on equity of --.

Balchem has a consensus price target of --, signalling upside risk potential of 14%. On the other hand 5E Advanced Materials has an analysts' consensus of $2.75 which suggests that it could grow by 231.63%. Given that 5E Advanced Materials has higher upside potential than Balchem, analysts believe 5E Advanced Materials is more attractive than Balchem.

Balchem has a beta of 0.668, which suggesting that the stock is 33.165% less volatile than S&P 500. In comparison 5E Advanced Materials has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.52%. 5E Advanced Materials offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Balchem pays 21.07% of its earnings as a dividend. 5E Advanced Materials pays out -- of its earnings as a dividend. Balchem's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are larger than 5E Advanced Materials quarterly revenues of --. Balchem's net income of $33.8M is higher than 5E Advanced Materials's net income of -$12.9M. Notably, Balchem's price-to-earnings ratio is 44.88x while 5E Advanced Materials's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.78x versus -- for 5E Advanced Materials. Usually stocks with elevated PS ratios are considered overvalued.

Innospec has a net margin of 14.1% compared to Balchem's net margin of 7.53%. Balchem's return on equity of 11.16% beat Innospec's return on equity of 12.17%.

Balchem has a consensus price target of --, signalling upside risk potential of 14%. On the other hand Innospec has an analysts' consensus of -- which suggests that it could grow by 17.68%. Given that Innospec has higher upside potential than Balchem, analysts believe Innospec is more attractive than Balchem.

Balchem has a beta of 0.668, which suggesting that the stock is 33.165% less volatile than S&P 500. In comparison Innospec has a beta of 1.086, suggesting its more volatile than the S&P 500 by 8.649%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.52%. Innospec offers a yield of 1.39% to investors and pays a quarterly dividend of $0.79 per share. Balchem pays 21.07% of its earnings as a dividend. Innospec pays out 25.23% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are smaller than Innospec quarterly revenues of $443.4M. Balchem's net income of $33.8M is higher than Innospec's net income of $33.4M. Notably, Balchem's price-to-earnings ratio is 44.88x while Innospec's PE ratio is 19.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.78x versus 1.49x for Innospec. Usually stocks with elevated PS ratios are considered overvalued.

The Mosaic has a net margin of 14.1% compared to Balchem's net margin of 4.35%. Balchem's return on equity of 11.16% beat The Mosaic's return on equity of 3.06%.

Balchem has a consensus price target of --, signalling upside risk potential of 14%. On the other hand The Mosaic has an analysts' consensus of $32.77 which suggests that it could grow by 35.02%. Given that The Mosaic has higher upside potential than Balchem, analysts believe The Mosaic is more attractive than Balchem.

Balchem has a beta of 0.668, which suggesting that the stock is 33.165% less volatile than S&P 500. In comparison The Mosaic has a beta of 1.343, suggesting its more volatile than the S&P 500 by 34.286%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.52%. The Mosaic offers a yield of 3.46% to investors and pays a quarterly dividend of $0.21 per share. Balchem pays 21.07% of its earnings as a dividend. The Mosaic pays out 30.18% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are smaller than The Mosaic quarterly revenues of $2.8B. Balchem's net income of $33.8M is lower than The Mosaic's net income of $122.2M. Notably, Balchem's price-to-earnings ratio is 44.88x while The Mosaic's PE ratio is 21.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.78x versus 0.68x for The Mosaic. Usually stocks with elevated PS ratios are considered overvalued.

WD-40 has a net margin of 14.1% compared to Balchem's net margin of 12.8%. Balchem's return on equity of 11.16% beat WD-40's return on equity of 32.43%.

Balchem has a consensus price target of --, signalling upside risk potential of 14%. On the other hand WD-40 has an analysts' consensus of -- which suggests that it could grow by 21.46%. Given that WD-40 has higher upside potential than Balchem, analysts believe WD-40 is more attractive than Balchem.

Balchem has a beta of 0.668, which suggesting that the stock is 33.165% less volatile than S&P 500. In comparison WD-40 has a beta of -0.069, suggesting its less volatile than the S&P 500 by 106.935%.

Balchem has a quarterly dividend of $0.87 per share corresponding to a yield of 0.52%. WD-40 offers a yield of 1.42% to investors and pays a quarterly dividend of $0.88 per share. Balchem pays 21.07% of its earnings as a dividend. WD-40 pays out 67.78% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Balchem quarterly revenues are $239.9M, which are larger than WD-40 quarterly revenues of $155M. Balchem's net income of $33.8M is higher than WD-40's net income of $19.8M. Notably, Balchem's price-to-earnings ratio is 44.88x while WD-40's PE ratio is 48.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Balchem is 5.78x versus 5.70x for WD-40. Usually stocks with elevated PS ratios are considered overvalued.